Acelrx Pharmaceuticals reported $-6739000 in Pre-Tax Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Acelrx Pharmaceuticals ACRX:US USD -6739000 1.75M
Baxter International BAX:US USD 534M 13M
Becton, Dickinson and BDX:US USD 926.97M 25.03M
Cara Therapeutics CARA:US USD -30339000 7.16M
Heron Therapeutics HRTX:US USD -41882000 14.48M
Intra Cellular Therapies ITCI:US USD -44026000 9.48M
Johnson & Johnson JNJ:US USD 7.42B 655M
Pfizer PFE:US USD 7.38B 3.3B
Teva Pharmaceutical TEVA:IT USD -1100000000 1.87B
Xeris Pharmaceuticals Inc XERS:US USD -13268000 8.9M